WF7-26530-81573
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2021-05-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-29
Dose 1 — Pfizer-BioNTech
-
2021-05-20
Dose 2 — Pfizer-BioNTech
-
2021-05-22
Registered in v-safe
-
2021-05-22
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-06-17
- 2021-06-24
- 2021-07-01
- 2021-08-19
- 2021-11-18
-
2022-05-22
Survey response — 12 months, dose 2MedDRA: Gestational diabetes, Nasopharyngitis, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Cold and gestational diabetes · Healthcare visit (other): OBGN visitMedDRA releases: 2024-11 · check-in free text available
-
2022-05-22
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-05-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-29 | Pfizer-BioNTech | |
| 2 | 2021-05-20 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-22 | Unsuccessful |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Vertigo
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release